These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30421200)

  • 1. [Anticoagulation for stroke prevention in atrial fibrillation - new concepts, new challenges].
    Remmel M; Blankenberg S
    MMW Fortschr Med; 2018 Nov; 160(Suppl 3):34-38. PubMed ID: 30421200
    [No Abstract]   [Full Text] [Related]  

  • 2. Unanswered questions and research priorities to optimise stroke prevention in atrial fibrillation with the new oral anticoagulants.
    Hankey GJ
    Thromb Haemost; 2014 May; 111(5):808-16. PubMed ID: 24285341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation.
    Fernandez MM; von Schéele B; Hogue S; Kwong WJ
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):87-102. PubMed ID: 23572283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update on Anticoagulation in Atrial Fibrillation.
    Amerena J; Ridley D
    Heart Lung Circ; 2017 Sep; 26(9):911-917. PubMed ID: 28684097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomes.
    Nieuwlaat R; Connolly SJ
    Heart; 2009 Feb; 95(2):95-7. PubMed ID: 18952632
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anticoagulation for patients with non-valvular atrial fibrillation].
    Mizoguchi T; Yasaka M
    Nihon Rinsho; 2016 Apr; 74(4):627-33. PubMed ID: 27333751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
    Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS
    Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Stroke prevention in atrial fibrillation.
    Voukalis C; Shantsila E; Lip GY
    J R Coll Physicians Edinb; 2017 Mar; 47(1):13-23. PubMed ID: 28569277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.
    Aguilar MI; Kuo RS; Freeman WD
    Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control.
    Janzic A; Kos M
    Pharmacoeconomics; 2015 Apr; 33(4):395-408. PubMed ID: 25512096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the prescription right? A review of non-vitamin K antagonist anticoagulant (NOAC) prescriptions in patients with non-valvular atrial fibrillation. Safe prescribing in atrial fibrillation and evaluation of non-vitamin K oral anticoagulants in stroke prevention (SAFE-NOACS) group.
    Pharithi RB; Ranganathan D; O'Brien J; Egom EE; Burke C; Ryan D; McAuliffe C; Vaughan M; Coughlan T; Morrissey E; McHugh J; Moore D; Collins R
    Ir J Med Sci; 2019 Feb; 188(1):101-108. PubMed ID: 29860595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of cardiovascular events and incident atrial fibrillation in patients without prior atrial fibrillation: Implications for expanding the indications for anticoagulation.
    Yao X; Gersh BJ; Sangaralingham LR; Shah ND; Noseworthy PA
    Am Heart J; 2018 May; 199():137-143. PubMed ID: 29754652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation for Stroke Prevention in Atrial Fibrillation.
    Krepostman N; Kramer HJ
    Am J Kidney Dis; 2022 Nov; 80(5):561-563. PubMed ID: 36057469
    [No Abstract]   [Full Text] [Related]  

  • 14. Stroke Prevention in Atrial Fibrillation: The Role of Oral Anticoagulation.
    Mtwesi V; Amit G
    Med Clin North Am; 2019 Sep; 103(5):847-862. PubMed ID: 31378330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke.
    Hoyer C; Filipov A; Neumaier-Probst E; Szabo K; Ebert A; Alonso A
    J Thromb Thrombolysis; 2018 May; 45(4):529-535. PubMed ID: 29476304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stroke prevention in patients with atrial fibrillation].
    Sirimarco G; Hirt L; Sztajzel R; Perren F
    Rev Med Suisse; 2017 Apr; 13(560):911-915. PubMed ID: 28727359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation in atrial fibrillation and chronic heart failure: the risk and drug of choice.
    Boos CJ; Brown L
    Curr Opin Cardiol; 2016 Mar; 31(2):229-34. PubMed ID: 26569089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
    Potpara TS; Larsen TB; Deharo JC; Rossvoll O; Dagres N; Todd D; Pison L; Proclemer A; Purefellner H; Blomström-Lundqvist C;
    Europace; 2015 Jun; 17(6):986-93. PubMed ID: 26023177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation in atrial fibrillation and flutter.
    Scholten MF; Thornton AS; Mekel JM; Koudstaal PJ; Jordaens LJ
    Europace; 2005 Sep; 7(5):492-9. PubMed ID: 16087116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
    Senoo K; Lip GY
    Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.